Not yet recruitingPhase 4NCT06460545

Phase IV Study of Concomitant Administration of the sIPV and HepA

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Principal Investigator
Jiawei Xu, MD
Chongqing Center for Disease Control and Prevention
Intervention
sIPV (booster dose at 18 months of age)(biological)
Enrollment
2000 target
Eligibility
All sexes
Timeline
20242027

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06460545 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials